CADL ▲ +3.3% - Candel Therapeutics, Inc.
$CADL - Candel Therapeutics Announces Late-Breaking Abstract Accepted for Poster Presentation at the SITC 2026 Annual Meeting, Featuring Aglatimagene Besadenovec Data in Localized Prostate Cancer
29-OCT-2026 09:00 AM ET
Share this post
More filings for $CADL
CADL ▲ +1.5% - Candel Therapeutics, Inc.Oct 27, 2026CADL ▲ +1.8% - Candel Therapeutics, Inc.Oct 22, 2026CADL ▲ +1.2% - Candel Therapeutics, Inc.Oct 22, 2026CADL ▲ +1.9% - Candel Therapeutics, Inc.Oct 2, 2026CADL ▼ -2.6% - Candel Therapeutics, Inc.Oct 1, 2026CADL ▼ -0.3% - Candel Therapeutics, Inc.Oct 1, 2026
View full $CADL filing history →💬 Comments
Loading comments…
Leave a comment